Phillip Williamson

472 total citations
9 papers, 77 citations indexed

About

Phillip Williamson is a scholar working on Infectious Diseases, Management of Technology and Innovation and Pathology and Forensic Medicine. According to data from OpenAlex, Phillip Williamson has authored 9 papers receiving a total of 77 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 2 papers in Management of Technology and Innovation and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Phillip Williamson's work include SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 Clinical Research Studies (4 papers) and SARS-CoV-2 detection and testing (3 papers). Phillip Williamson is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 Clinical Research Studies (4 papers) and SARS-CoV-2 detection and testing (3 papers). Phillip Williamson collaborates with scholars based in United States, Canada and South Africa. Phillip Williamson's co-authors include Jonathan Elford, B. Tindall, JM Kaldor, D. A. Cooper, Mars Stone, Eduard Grebe, Michael P. Busch, Debra Kessler, Susan L. Stramer and Clara Di Germanio and has published in prestigious journals such as Blood, The Journal of Infectious Diseases and Journal of Applied Microbiology.

In The Last Decade

Phillip Williamson

9 papers receiving 76 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Phillip Williamson United States	5	58	22	16	13	10	9	77
Afsaneh Ghasemzadeh Iran	5	45 0.8×	11 0.5×	9 0.6×		2 0.2×	19	83
Vanessa Cui Lian Chong Singapore	4	79 1.4×	32 1.5×	14 0.9×		4 0.4×	5	111
Ahmed El Kalioubie France	2	60 1.0×	56 2.5×	22 1.4×		6 0.6×	2	122
Saba Gargouri Tunisia	6	34 0.6×	34 1.5×	3 0.2×		16 1.6×	12	72
Niklas Broman Finland	3	78 1.3×	17 0.8×	9 0.6×		3 0.3×	5	106
Bashir Aden United Arab Emirates	5	54 0.9×	5 0.2×	8 0.5×		5 0.5×	6	80
Jerry Cade United States	3	48 0.8×	58 2.6×	9 0.6×		6 0.6×	5	108
Lisa Bunts United States	4	30 0.5×	41 1.9×	45 2.8×		13 1.3×	5	68
Iran Barros Costa Brazil	5	23 0.4×	20 0.9×	27 1.7×		10 1.0×	9	49
Sin Young Ham South Korea	4	47 0.8×	13 0.6×	7 0.4×	1 0.1×	2 0.2×	13	77

Countries citing papers authored by Phillip Williamson

Since Specialization

Citations

This map shows the geographic impact of Phillip Williamson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip Williamson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip Williamson more than expected).

Fields of papers citing papers by Phillip Williamson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip Williamson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip Williamson. The network helps show where Phillip Williamson may publish in the future.

Co-authorship network of co-authors of Phillip Williamson

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip Williamson. A scholar is included among the top collaborators of Phillip Williamson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip Williamson. Phillip Williamson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Grebe, Eduard, Elaine A. Yu, Marjorie D. Bravo, et al.. (2022). Coronavirus Disease 2019 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the United States Before the Delta- and Omicron-Associated Surges: A Retrospective Cohort Study of Repeat Blood Donors. The Journal of Infectious Diseases. 226(9). 1556–1561. 4 indexed citations

Grebe, Eduard, Valerie Green, Alyce Linthurst Jones, et al.. (2022). Low rate of detection of SARS-CoV-2 RNA in deceased tissue donors. Cell and Tissue Banking. 24(3). 585–596. 1 indexed citations

Meyer, Erin, Graham Simmons, Eduard Grebe, et al.. (2021). Selecting COVID ‐19 convalescent plasma for neutralizing antibody potency using a high‐capacity SARS‐CoV ‐2 antibody assay. Transfusion. 61(4). 1160–1170. 12 indexed citations

Multari, Rosalie A., David A. Cremers, Ann Marie Nelson, et al.. (2021). The use of laser-based diagnostics for the rapid identification of blood borne viruses in human plasma samples. Journal of Applied Microbiology. 132(3). 2431–2440. 1 indexed citations

Bakkour, Sonia, Paula Saá, Leilani Montalvo, et al.. (2021). Minipool testing for SARS‐CoV‐2 RNA in United States blood donors. Transfusion. 61(8). 2384–2391. 15 indexed citations

Grebe, Eduard, Michael P. Busch, Edward P. Notari, et al.. (2020). HIV incidence in US first-time blood donors and transfusion risk with a 12-month deferral for men who have sex with men. Blood. 136(11). 1359–1367. 15 indexed citations

Quiner, Claire, Roberta Bruhn, Eduard Grebe, et al.. (2020). Recently acquired infection among HIV‐seropositive donors in the US from 2010‐2018. Transfusion. 60(10). 2340–2347. 3 indexed citations

Stone, Mars, Sonia Bakkour, Tzong‐Hae Lee, et al.. (2017). Zika RNA Persistence in Blood and Body Fluids and Clinical Outcomes in Infected Blood Donors. 5 indexed citations

Kaldor, JM, B. Tindall, Phillip Williamson, Jonathan Elford, & D. A. Cooper. (1993). Factors associated with Kaposi's sarcoma in a cohort of homosexual and bisexual men.. PubMed. 6(10). 1145–9. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact